RR interval variability in the evaluation of ventricular tachycardia and effects of implantable cardioverter defibrillator therapy

BACKGROUND: An implantable cardioverter defibrillator (ICD) is the most reliable therapeutic device for preventing sudden cardiac death in patients with sustained ventricular tachycardia (VT). Regarding its effectiveness, targeted VT is defined based on the tachyarrhythmia cycle length. However, var...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsukahara, Keita, Oginosawa, Yasushi, Fujino, Yoshihisa, Honda, Toshihiro, Kikuchi, Kan, Nozoe, Masatsugu, Uchida, Takayuki, Minamiguchi, Hitoshi, Sonoda, Koichiro, Ogawa, Masahiro, Ideguchi, Takeshi, Kizaki, Yoshihisa, Nakamura, Toshihiro, Oba, Kageyuki, Higa, Satoshi, Yoshida, Keiki, Yagyu, Keishiro, Miyamoto, Taro, Yamagishi, Yasunobu, Ohe, Hisaharu, Kohno, Ritsuko, Kataoka, Masaharu, Otsuji, Yutaka, Abe, Haruhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339111/
https://www.ncbi.nlm.nih.gov/pubmed/34386132
http://dx.doi.org/10.1002/joa3.12551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339111/
https://www.ncbi.nlm.nih.gov/pubmed/34386132
http://dx.doi.org/10.1002/joa3.12551

Ejemplares similares